Evolution of the Average Target: Bastide Le Confort Médical

Evolution of the Average Target - Bastide Le Confort Médical

Evolution of the Target Price: Bastide Le Confort Médical

Evolution of the Target Price - Bastide Le Confort Médical

Changes in Analyst Recommendations: Bastide Le Confort Médical

01289aa82.qP6RXXtPuVFSIeXY_SYq_XitHReC0z6yn2Pht17W9hI.zIrWAjMl_Gkza4q2nk1zuUzGR2fnnVL8_CiXxS77nVWRsKNvFh3KFghNqA~99c9983b3b21507af07d864ad4ab44ed
28/09 AlphaValue/Baader Europe Upgrades Bastide Le Confort Médical to Buy MT
04/09 Bastide Le Confort Medical: FY sales beat guidance - end of coverage on 1st of October Alphavalue
18/05 Baader Europe maintains stance on Bastide le Confort Médical Zonebourse
15/05 Bastide Le Confort Medical: Guidance confirmed despite transitory regulatory headwinds in Q3 Alphavalue
20/03 Bastide Le Confort Medical: Sound H1 results, solid deleveraging, and reaffirmed FY guidance Alphavalue
20/03 Bastide results in line with guidance, says Oddo BHF Zonebourse
05/12 Bastide Le Confort Medical cuts EPS guidance Alphavalue
28/10/25 Bastide Le Confort Medical: In-line FY24/25 underlying results; smooth deleveraging Alphavalue
06/09/25 Bastide Le Confort Medical: In-line FY24/25 revenue; reconfirmed guidance Alphavalue
05/07/25 Bastide Le Confort Medical: Impact of strategic divestitures effective from next FY Alphavalue
06/06/25 Bastide: Oddo BHF still a buyer Zonebourse
16/05/25 Bastide Le Confort Medical: Reconfirmed guidance backed by compelling 9M turnover Alphavalue
21/03/25 Bastide Le Confort Medical: EPS cut (2024: -52.7%, 2025: -37.4%) Alphavalue
21/03/25 Bastide Le Confort Medical: Profitability gains neutralized by heavier financial expenses Alphavalue
20/03/25 Bastide: price target raised by Oddo BHF Zonebourse
15/03/25 Bastide Le Confort Medical: Debt reduction on the right trajectory Alphavalue
14/02/25 Bastide Le Confort Medical: Crystallizing a better revenue mix Alphavalue
28/11/24 Bastide: up sharply, a broker raises his recommendation Zonebourse
27/11/24 Bastide: Oddo BHF upgrades to 'outperform', raises target Zonebourse
15/11/24 Bastide Le Confort Medical: Better revenue mix; progress in portfolio review Alphavalue
29/10/24 Bastide Le Confort Medical: Margin build-up and debt reduction on a good trajectory Alphavalue
30/08/24 Bastide Le Confort Medical: Stronger qoq organic growth; guidance reiterated Alphavalue
16/05/24 Bastide Le Confort Medical: De facto maintained guidance; more disposals to propel debt reduction Alphavalue
09/04/24 Bastide Le Confort Medical: EPS upgrade (2023: 0.0%, 2024: +1.6%) Alphavalue
21/03/24 Bastide Le Confort Medical: The prioritised debt reduction awaits further visible progress Alphavalue

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
- +45.95%
+27.96%
-0.69%
+0.5%
+4.28%
+18.02%
+2.16%
+6.2%
+19.93%
+31.59%
Average +15.59%
Weighted average by Cap. +11.90%


Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
18.50EUR
Average target price
27.00EUR
Spread / Average Target
+45.95%
High Price Target
31.00EUR
Spread / Highest target
+67.57%
Low Price Target
23.00EUR
Spread / Lowest Target
+24.32%

Analyst Consensus Detail

Analyst consensus - Bastide Le Confort Médical

Consensus revision (last 18 months)

Consensus revision (last 18 months) - Bastide Le Confort Médical
Trader
Investor
Global
Quality
ESG MSCI
-
MarketScreener Ratings - Bastide Le Confort Médical
  1. Stock Market
  2. Stocks
  3. BLC Stock
  4. Consensus Bastide Le Confort Médical